NeuPath Health Inc is experiencing a positive week, with notable movements in its stock price and market activity.
NeuPath Health Inc (NPTH.V) has seen a 3.70% increase in its stock price this week, closing at C$0.57. This performance reflects steady growth, supported by solid fundamentals and recent developments in the healthcare sector.
Advertisement
NeuPath Health Inc
NPTH.V
NPTH.V
NeuPath Health Inc
WealthAwesomeMarket cap
$30.77M
P/E
27.0x
52W high
$0.68
52W low
$0.31
1W change
+3.70%
Beta
0.91
Analyst Price Targets
Based on analyst covering NPTH · as of Sep 17, 2026
Wall Street analysts forecast NPTH stock price to rise 45.5% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.81
+45.5% Upside
Current Price
C$0.56
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on NPTH's historical volatility
30-Day Vol
59.7%
Annualized
90-Day Vol
53.1%
Annualized
Trend (90d)
-49.5%
Annualized drift
90d Mean
C$0.47
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.53 | C$0.43 – C$0.65 |
| 60 trading days | C$0.50 | C$0.37 – C$0.67 |
| 90 trading days | C$0.47 | C$0.33 – C$0.67 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: For those considering NeuPath Health, the recent price increase and the company's fundamentals suggest a cautiously optimistic outlook. However, it's important to keep an eye on market conditions and company developments.
NeuPath Health Inc shares rise 3.70% this week.
With a market capitalization of approximately C$30.77 million and a P/E ratio of 27, NeuPath Health is navigating a complex landscape in the healthcare sector.
Bull case
NeuPath Health's stock has shown resilience, with a year-to-date increase of 7.69%, indicating investor confidence. Analysts have an average target of C$0.81, suggesting potential upside and reflecting a bullish outlook for the company.
Bear case
Despite the positive momentum, NeuPath Health's profit margin of 1.5% raises concerns about profitability. Additionally, the stock's beta of 0.91 indicates it is less volatile than the market, which could limit significant upward price movements.
Recent Price Action
This week, NeuPath Health Inc saw its stock price increase by 3.70%, closing at C$0.57. This upward movement is significant as it reflects consistent performance, with the stock also achieving a year-to-date increase of 7.69%. Despite fluctuations, the stock has remained within its 52-week range of C$0.31 to C$0.68, indicating a stable trading environment.
Company News
Advertisement
On October 6, 2026, Cantech announced the finalists for the 2025-26 Cantech Letter Awards. This could impact NeuPath Health as it works to establish its presence in the healthcare sector. While specific details about the company's recognition are not provided, such awards can enhance visibility and credibility, potentially influencing investor sentiment.
Technical Picture
From a technical standpoint, NeuPath Health's stock is currently trading at its 50-day moving average of C$0.57, slightly below this average by 0.5%. The 200-day moving average stands at C$0.55, representing a 4.2% increase compared to the current price. The stock's beta of 0.91 suggests it is less volatile than the broader market, which may appeal to risk-averse investors. The latest trading volume of 101,503 shares is about 0.25 times the 20-day average volume of 79,806 shares, indicating moderate trading activity.
Insider Activity
No recent insider activity has been reported for NeuPath Health Inc, which may suggest stability in management and ownership structures at this time.
Price Action Summary
NeuPath Health Inc closed at C$0.57, reflecting a 3.70% increase over the past week. Investors should watch for future developments as the company navigates the healthcare landscape.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
